Submissions

Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024
April 2024

Submissions

The Health Technology Assessment (HTA) Policy and Methods Review – Consultation 2
February 2024

Submissions

RANZCR Theranostics Professional Development Guideline
February 2024

Submissions

Equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer
August 2023

Submissions

177Lutetium (n.c.a) Octreotate treatment for advanced neuroendocrine and other high somatostatin receptor expressing tumours (MSAC application 1744)
July 2023

Submissions

The Health Technology Assessment (HTA) Policy and Methods Review
June 2023